Study design and population.
The BCG-Corona trial was a multicenter, double-blind, placebo-controlled randomized trial comparing BCG to placebo vaccination to prevent absenteeism and COVID-19-related endpoints. The study protocol was approved by the institutional review board of the University Medical Center (UMC) Utrecht, registered at clinicaltrials.gov (identifier NCT04328441), and published (